跳至主要内容
临床试验/NCT05229744
NCT05229744终止不适用

Prevalence of Endolymphatic Hydrops in Patients With a History of Congenital Cytomegalovirus Infection With Symptomatic Cochleo-vestibular Involvement

Fondation Ophtalmologique Adolphe de Rothschild2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2022年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
18
试验地点
2
主要终点
the prevalence of at least one endolymphatic hydrops in patients with a history of congenital CMV infection with symptomatic cochleovestibular dysfunction

研究概览

简要总结

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.

详细描述

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.

Patients benefit as part of the care:

  • A clinical cochleo-vestibular examination
  • Functional otoneurological explorations: audiogram, caloric tests, vHIT, otolithic evoked potentials
  • From an uninjected brain MRI

Participation in this research entails the addition of an MRI sequence and an injection of contrast product (Gadovist®):

- 3D FLAIR MRI sequence dedicated to the exploration of the inner ear, lasting 6min30s, performed 4 hours after the initial injection of contrast product.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient over 6 months old
  • With a history of confirmed congenital CMV infection
  • Suffering from symptomatic cochleo-vestibular dysfunction (average hearing threshold> 20dB in at least one ear and / or abnormal functioning of one or more sectors at the vestibular level)
  • For adult patients, having received informed information about the study and having signed a consent to participate in the study
  • For minor patients written consent of the two holders of the exercise of parental authority
  • Affiliate or beneficiary of a social security scheme

排除标准

  • Patient benefiting from a legal protection measure
  • Pregnant or breastfeeding woman
  • Contraindication to MRI (implanted electrical device, metallic foreign body, claustrophobia)
  • Patient with a proven allergy to gadolinium
  • Injection of gadolinium in the previous 7 days
  • Known impairment of renal function ((estimated GFR <60 mL / min / 1.73 m²)

结局指标

主要结局

the prevalence of at least one endolymphatic hydrops in patients with a history of congenital CMV infection with symptomatic cochleovestibular dysfunction

时间窗: 4 hours after the initial injection of gadolinium, at least for one of the two ears

Endolymphatic hydrops visualized with 3D FLAIR sequence in MRI

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验